Allogene Therapeutics, Inc. (ALLO)
2.035
-0.06
(-2.63%)
USD |
NASDAQ |
Aug 24, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Shareholders Equity (Quarterly) : 436.18M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 436.18M |
| March 31, 2026 | 278.88M |
| December 31, 2025 | 292.54M |
| September 30, 2025 | 315.33M |
| June 30, 2025 | 344.56M |
| March 31, 2025 | 385.39M |
| December 31, 2024 | 422.18M |
| September 30, 2024 | 463.75M |
| June 30, 2024 | 515.04M |
| March 31, 2024 | 461.37M |
| December 31, 2023 | 512.23M |
| September 30, 2023 | 583.10M |
| June 30, 2023 | 622.91M |
| March 31, 2023 | 592.26M |
| December 31, 2022 | 665.87M |
| September 30, 2022 | 739.96M |
| June 30, 2022 | 801.95M |
| March 31, 2022 | 855.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 925.20M |
| September 30, 2021 | 969.94M |
| June 30, 2021 | 1.024B |
| March 31, 2021 | 1.070B |
| December 31, 2020 | 1.080B |
| September 30, 2020 | 1.119B |
| June 30, 2020 | 1.163B |
| March 31, 2020 | 606.52M |
| December 31, 2019 | 629.02M |
| September 30, 2019 | 619.72M |
| June 30, 2019 | 655.64M |
| March 31, 2019 | 681.23M |
| December 31, 2018 | 703.16M |
| September 30, 2018 | 242.61M |
| June 30, 2018 | 131.61M |
| March 31, 2018 | |
| December 31, 2017 | 0.003M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | -125.23M |
| Beam Therapeutics, Inc. | 1.067B |
| Kyverna Therapeutics, Inc. | 165.55M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 550.09M |
| Total Liabilities (Quarterly) | 113.92M |
| Debt to Equity Ratio | 0.1811 |
| Current Ratio | 10.72 |
| Net Debt Paydown Yield | 0.28% |